Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.5 CNY 0.66% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Interest Income Expense
ÂĄ34.9m
CAGR 3-Years
27%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Interest Income Expense
-ÂĄ338.8m
CAGR 3-Years
-10%
CAGR 5-Years
11%
CAGR 10-Years
-2%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Interest Income Expense
ÂĄ40.5m
CAGR 3-Years
20%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Interest Income Expense
ÂĄ36.1m
CAGR 3-Years
151%
CAGR 5-Years
21%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Interest Income Expense
ÂĄ91.3m
CAGR 3-Years
-38%
CAGR 5-Years
3%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Interest Income Expense
ÂĄ77.8m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Intrinsic Value
33.81 CNY
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
34.9m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Interest Income Expense amounts to 34.9m CNY.

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
21%

Over the last year, the Interest Income Expense growth was 137%. The average annual Interest Income Expense growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been 27% over the past three years , 21% over the past five years .

Back to Top